Evaluation of the tolerability and safety of a 0.015% ingenol mebutate gel compared to 5% 5‐fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 9, 2015-09 ,pp. : 1822-1827

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase IV head‐to‐head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : e162-e162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase IV head‐to‐head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 433-442

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment monitoring of topical ingenol mebutate in actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy: a case series

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 816-818

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 11, 2015-11 ,pp. : 2192-2198

John Wiley & Sons Inc

Access to resources Recommend Favorite